Issue 230

14.01.2022

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

GROWTH OF MEDICAL CANNABIS SALES IN GERMANY IS FALTERING

New data on reimbursements for medical cannabis released by The German National Association of Statutory Health Insurance Funds (GKV) shows that sales of medical cannabis have stagnated over recent quarters, with Q3 of 2021 having almost the identical value of sales as Q3 of 2020.

The reimbursed market grew by 7% for the nine months ending December 2021, compared to the same period in 2020. This data represents sales of medical cannabis that have been reimbursed by public health insurers, which cover 90% of the German population. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still relatively low, with one issue being that doctors are often unwilling to prescribe cannabis.

READ MORE »

 


 

RECENT DATA SHOWS CANNABIS REDUCES OPIATE USE BY 40% IN ISRAEL

READ MORE »

EXPERT INTERVIEW: GIORGIO FERDINANDI, CHIEF SALES OFFICER, LINNEA

READ MORE »

Europe

USA

  • Experts exercise caution over 2022 growth predictions as US cannabis sales hit US$37.4 billion in 2021.
  • California’s cannabis department is awarding US$100 million to support the local cannabis market.
  • Washington is falling behind other states in regulation and taxes to support the cannabis industry.
  • A new Republican-led bill has landed in the state of Kentucky which could see medical cannabis legalised.
  • State lawmakers in South Dakota are working on more than two dozen cannabis reform bills this month.
  • Governor threatens to veto cannabis bill despite the Mississippi Senate Committee approving the notion.
  • The Director of National Intelligence says employers shouldn’t reject applicants over past cannabis use.
  • Suppliers state that demand is high since a new smokable form of cannabis became legal in Louisiana.
  • Matt Karnes joins Business of Cannabis Live to discuss how New York legalisation impacts the sector.
  • A US study suggests that compounds in cannabis could prevent people from catching COVID-19.

UPCOMING EVENT

EARLY BIRD TICKET SALES FOR CANNABIS EUROPA LONDON – ENDING SOON!

2022 is set to be another significant year for cannabis in Europe. With the coalition government in Germany announcing its intentions to legalise adult-use cannabis, and a swathe of legislative changes expected elsewhere in Europe in the coming 12-24 months, the continent’s cannabis industry is arguably entering its most pivotal phase, as the industry strives for normalisation and to go mainstream.

Cannabis Europa returns to London on 28-29 June 2022 for our biggest and most ambitious event to date – delivering cutting-edge knowledge and networking opportunities, paramount to driving growth across the sector. We want you to be a part of it.

SUBSCRIBE NOW »

CANADA

  • Canadian minister announces that only the vaccinated will be allowed in cannabis stores in Quebec.
  • Organigram’s Q1 revenue is set to reach a record C$30.4 million as it increased by 22% from Q4 2021.
  • Leafly and Merida Merger Corp. enter into a C$30 million purchase agreement with new investors.
  • Brewing firm Anheuser-Busch InBev is committed to making CBD-infused non-alcoholic drinks in Canada.
  • Canada’s cannabis report shows that Canadians’ attitudes on cannabis haven’t changed in 2021.
  • A British Columbia airport could be the world’s first to open a cannabis retail store.

LATAM & CARIBBEAN

EXCLUSIVE

THE GLOBAL CANNABIS LEGALISATION OVERVIEW

As we look forward into 2022 and the new hopes it brings, we look at which countries – from Canada to Croatia, Australia to Argentina and Malta to Morocco – are relaxing their legislation and leaning towards more progressive policy on cannabis.

At the time of writing, only Canada, Uruguay and 21 states in the US, including Washington D.C. and Guam, have legalised adult-use cannabis, but this is expected to increase at pace over the next five years, as the economic, health and justice benefits become clearer to regulators around the world. We’ve put together an overview of the rules and regulations currently in place across the globe. Explore each region using our intuitive interactive map.

MARKET SIZING + REAL WORLD DATA NOW AVAILABLE »

APAC

 

AFRICA & MIDDLE EAST

Read the stories that shape the cannabis industry